SHUKRA PHARMACEUTICALS
Back to Cashflow Statement
|
SHUKRA PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-4.52 Cr | ₹12 Cr | ₹4.94 Cr | ₹-6.68 Cr | ₹1.74 Cr |
What is the latest Cash Flow from Financing Activities ratio of SHUKRA PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-4.52 Cr |
| Mar2024 | ₹12 Cr |
| Mar2023 | ₹4.94 Cr |
| Mar2022 | ₹-6.68 Cr |
| Mar2021 | ₹1.74 Cr |
How is Cash Flow from Financing Activities of SHUKRA PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-4.52 Cr | Negative | |
| Mar2024 | ₹12 Cr | 151.06 | |
| Mar2023 | ₹4.94 Cr | Positive | |
| Mar2022 | ₹-6.68 Cr | Negative | |
| Mar2021 | ₹1.74 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹2,226.3 Cr | 9.1% | -14.1% | 178.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,541.0 Cr | -3.6% | -6.8% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,031.0 Cr | -5.4% | -2.4% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,451.0 Cr | 3.6% | 8.5% | 23.5% | Stock Analytics | |
| CIPLA | ₹112,377.0 Cr | -5.1% | -7.1% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,355.5 Cr | -4.1% | -8.3% | -12.1% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | 9.1% |
-14.1% |
178.9% |
| SENSEX | -0.4% |
-1.7% |
9.1% |
You may also like the below Video Courses